在胆汁反流性胃炎中使用乌尔索酸的临床有效性:系统性审查和元分析
Zi-Yu Wu1, Meng-Han Zhang1, Yue Li1
1Gastroenterology Department, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing, 100700, China.
Digestive diseases and sciences
|August 24, 2025
概括
通过减少反流发作和缓解症状,乌尔索多西可酸 (UDCA) 显著改善了胆汁反流性胃炎 (BRG). 这一元分析支持UDCA作为BRG的潜在一线治疗方法.
科学领域:
- 胃肠病学
- 药理学
背景情况:
- 胆汁反流性胃炎 (BRG) 是一种可能导致癌前胃病变和胃癌的疾病.
- 对于治疗BRG的乌尔索多醇酸 (UDCA) 的临床疗效尚未得到充分证实.
研究的目的:
- 与BRG常规治疗相比,系统评估UDCA的疗效和安全性.
主要方法:
- 对14项涉及1605名患者的研究进行了分析.
- 使用森林地块评估结果,并通过元回归分析评估异质性.
- 研究的质量和证据分级使用了Cochrane风险偏差2工具,纽卡斯尔- 太华尺度和GRADE方法.
主要成果:
- 与药物联合使用的UDCA显著减少了反流发作及其持续时间.
- 它还减少了长期反流发作,增加了临床反应率,并降低了胃素水平.
- 随着UDCA治疗,与BRG相关的症状得到缓解.
结论:
- 在治疗BRG方面,UDCA具有显著的疗效.
- 一个8周的UDCA疗程似乎特别有效.
- UDCA显示为BRG的第一线治疗选择.
相关概念视频
Peptic Ulcer Disease IV: Management
145
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
145
Gastritis III: Clinical Manifestations and Management
474
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
474
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
687
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
687
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
569
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
569
Drugs for Treatment of Ulcerative Colitis in IBD
236
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
236
Gastroesophageal Reflux Disease II: Clinical Features and Management
199
Gastroesophageal reflux disease, or GERD, is a persistent medical condition that affects many individuals worldwide. Its clinical manifestations can vary greatly, making diagnosis and management challenging for healthcare professionals. The following is a comprehensive overview of the clinical manifestations, assessment, and management strategies for GERD.
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
Clinical Manifestations
GERD presents itself in a multitude of ways, with symptoms varying from person to person. The hallmark symptoms are...
199


